A Study of Niraparib in Combination With Brivanib in Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)
- Status
- TERMINATED
- Phase
- PHASE2
Comparison to Psychological, Medical and Emotional Influencing Communication and Achievement Factors to Oncogenetics Tests
- Status
- COMPLETED
- Phase
- N/A
Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Pre-screening Protocol for Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Impact of Disney Movies During Chemotherapy on QOL of Gynecologic Oncology Patients
- Status
- COMPLETED
- Phase
- NA
A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE4
The IGF Axis Involvement in Immune Tumor Microenvironment in Ovarian Cancer and Its Clinical Significance
- Status
- UNKNOWN
- Phase
- N/A
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Expanded Access of Vigil in Solid Tumors
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy
- Status
- COMPLETED
- Phase
- N/A
Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Constitution of ex Vivo Ovarian Tumor Models for the Validation of the Interest of Innovative Therapies and the Search for Tumor or Circulating Biomarkers Predictive of Treatment Response
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Paclitaxel for Injection (Albumin-bound) for First-line Chemotherapy of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Imaging Study in Advanced Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A